Dana Investment Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-92,305
| Closed | -$8.58M | – | 323 |
|
|
2021
Q1 | $8.58M | Buy |
92,305
+103
| +0.1% | +$9.57K | 0.4% | 73 |
|
|
2020
Q4 | $8.26M | Buy |
92,202
+13,898
| +18% | +$1.25M | 0.41% | 76 |
|
|
2020
Q3 | $8.09M | Sell |
78,304
-29,523
| -27% | -$3.05M | 0.44% | 74 |
|
|
2020
Q2 | $8.53M | Sell |
107,827
-20,164
| -16% | -$1.59M | 0.46% | 73 |
|
|
2020
Q1 | $7.41M | Sell |
127,991
-13,917
| -10% | -$805K | 0.45% | 67 |
|
|
2019
Q4 | $7.66M | Sell |
141,908
-33,150
| -19% | -$1.79M | 0.37% | 73 |
|
|
2019
Q3 | $9.15M | Sell |
175,058
-54,268
| -24% | -$2.84M | 0.46% | 71 |
|
|
2019
Q2 | $11.1M | Sell |
229,326
-38,579
| -14% | -$1.86M | 0.55% | 71 |
|
|
2019
Q1 | $13.5M | Buy |
267,905
+17,043
| +7% | +$861K | 0.64% | 61 |
|
|
2018
Q4 | $14.9M | Buy |
250,862
+143,023
| +133% | +$8.48M | 0.76% | 49 |
|
|
2018
Q3 | $7.1M | Sell |
107,839
-3,907
| -3% | -$257K | 0.29% | 85 |
|
|
2018
Q2 | $5.64M | Sell |
111,746
-12,574
| -10% | -$635K | 0.25% | 89 |
|
|
2018
Q1 | $6.55M | Buy |
+124,320
| New | +$6.55M | 0.29% | 82 |
|
|
2016
Q3 | – | Sell |
-44,966
| Closed | -$1.26M | – | 279 |
|
|
2016
Q2 | $1.26M | Buy |
44,966
+1,546
| +4% | +$43.5K | 0.06% | 201 |
|
|
2016
Q1 | $1.58M | Buy |
43,420
+41,621
| +2,314% | +$1.51M | 0.07% | 162 |
|
|
2015
Q4 | $1.8K | Sell |
1,799
-46,762
| -96% | -$46.8K | 0.09% | 141 |
|
|
2015
Q3 | $1.38M | Sell |
48,561
-10,138
| -17% | -$289K | 0.07% | 161 |
|
|
2015
Q2 | $1.93M | Buy |
58,699
+16,282
| +38% | +$536K | 0.09% | 135 |
|
|
2015
Q1 | $1.22M | Sell |
42,417
-1,227
| -3% | -$35.3K | 0.06% | 168 |
|
|
2014
Q4 | $1.19M | Buy |
43,644
+2,134
| +5% | +$58.1K | 0.05% | 161 |
|
|
2014
Q3 | $885K | Buy |
41,510
+5,998
| +17% | +$128K | 0.05% | 182 |
|
|
2014
Q2 | $798K | Buy |
+35,512
| New | +$798K | 0.05% | 202 |
|